Literature DB >> 22084603

Kynurenine pathway Hypothesis: The nature of the chronic Fatigue syndrome (cFs) Revisited.

Adele Blankfield1.   

Abstract

Entities:  

Year:  2011        PMID: 22084603      PMCID: PMC3195222          DOI: 10.4137/IJTR.S7898

Source DB:  PubMed          Journal:  Int J Tryptophan Res        ISSN: 1178-6469


× No keyword cloud information.

The Nature of the Chronic Fatigue Syndrome (CFS) Revisited

Moderate physicians consider CFS to be missed diagnoses of uncommon illnesses with atypical features. Hartnup (heterozygotes), Lyme and Whipples—like diseases are examples of conditions which fit these clinical ambiguities. The detractors claim it is non-existent. The protractors complain CFS is excluded from standard medical texts. A broad overview of medical literature and support group newsletters, render these opposing views substantially incorrect. The patient presents with a confounding array of neurological, mental, gastrointestinal, musculoskeletal and perhaps dermatological and visual signs and symptoms. Episodic night sweats can also be reported. Lack of energy, concentration and mobility, limit lifestyle. These symptom constellations evolve and fluctuate in a seemingly random order and can become entrenched. Alcohol intake, protracted steroid therapy and overt or latent infections usually aggravate the course of CFS. CFS patients often have positive family histories of mixed connective tissue disorders frequently combined with arthralgic and intestinal disorders. In addition, CFS patients may display stigmata of autoimmune inefficiencies with inability to show changes in critical clinical indicators. Temperature, FBE and ESR can be paradoxically “normal”.1 Propensity towards sero-negative variants are reflected in atypical Rheumatoid conditions or B12 deficiency with only achlorhydria and/or neurological deficits as definitive signs.2 Unusual cytokine profiles are recorded.3 The older post Freudian extensions of abstract somatoform theories, limits a clear view of CFS. More recent discovery of malabsorptive and other nutritional neuropathic states4 make cohesive sense out of the seemingly disparate multisystem CFS patterns. The resolution of diagnostic conundrums are certainly one essential part of the picture. They fail to explain why CFS minorities handle infections and multiple autoimmune disorders in a more malignant fashion, compared with large similar illness cohorts. Review host defence mechanisms. Starvation, malabsorption, maldigestion and food intolerances are companion to infection. The integrity of interwoven metabolic processes and immune factor formation require adequate substrate levels, an absence of inborn genetic errors and healthy balance of intestinal microorganisms. HIV aids depletes immune competence. Are there comparable organisms which downgrade pre-existing compromised CFS immune systems? Tryptophan was the only nutrient supplement to show CFS therapeutic promise.5 It participates in neuroconduction and immune functions. The Tryptophan/kynurenine pathways with glitched DOI enzyme and gamma-INF and/or other site interactions,2,6,7 might provide a salient key, to the immunology of chronic smouldering CFS infections8 and overall morbidity.
  3 in total

Review 1.  Nutritional strategies for treating chronic fatigue syndrome.

Authors:  M R Werbach
Journal:  Altern Med Rev       Date:  2000-04

2.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

3.  IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection.

Authors:  Rosa Bellmann-Weiler; Katharina Schroecksnadel; Claudia Holzer; Clara Larcher; Dietmar Fuchs; Guenter Weiss
Journal:  J Affect Disord       Date:  2007-10-22       Impact factor: 4.839

  3 in total
  3 in total

1.  A Brief Historic Overview of Clinical Disorders Associated with Tryptophan: The Relevance to Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2012-09-17

2.  Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.

Authors:  Adonis Sfera; Carolina Osorio; Carlos M Zapata Martín Del Campo; Shaniah Pereida; Steve Maurer; Jose Campo Maldonado; Zisis Kozlakidis
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

3.  Kynurenine Pathway Pathologies: do Nicotinamide and Other Pathway Co-Factors have a Therapeutic Role in Reduction of Symptom Severity, Including Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2013-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.